Delapril is a new angiotensin-converting enzyme (ACE) inhibitor useful in the treatment
of essential hypertension. Orally administered delapril is a prodrug which is de-esterified
to its active diacid metabolite. In hypertensive patients delapril significantly decreased
systolic blood pressure and ACE activity 24 hours after dosing without affecting
endogeneous creatinine clearance.
Delapril Hydrochloride is an angiotensin-converting-enzyme inhibitor (ACE) used as an antihypertensive drug in some European and Asian countries, but not in America.
Definition
ChEBI: Delapril hydrochloride is a peptide.
Brand name
Adecut
DELAPRIL HCL Preparation Products And Raw materials
